[Cytostatic agents administrated via a subcutaneous intravenous port: the course was a nightmare].
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects; D004868:Equipment Failure; D006801:Humans; D015918:Infusion Pumps, Implantable / Q000009:adverse effects*; D007262:Infusions, Intravenous / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*
D000970:Antineoplastic Agents
Cytostatika gavs via subkutan intravenös port: förloppet blev mardrömslikt.